Search results
US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition
Las Vegas Review-Journal· 38 minutes agoWASHINGTON — Federal regulators are challenging patents on 20 brand-name drugs, including the...
USPTO Issues Guidance on Use of AI-Based Tools
The National Law Review· 3 hours agoOn April 11, 2024, the U.S. Patent and Trademark Office (USPTO) issued Guidance on Use of Artificial-Intelligence-Based Tools (Guidance), which applies...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 3 hours agoHEALTH NEWS The Federal Trade Commission is challenging hundreds of pharmaceutical patent listings...
Ozempic and 19 other drugs have 'junk' patents, the FTC says in a new challenge
Quartz· 5 hours agoThe U.S. Federal Trade Commission (FDA) announced on Tuesday that it is disputing over 300 patent...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 7 hours agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
FTC cracks down on drugmaker patents, including Novo's Ozempic; analysts weigh in By Investing.com
Investing.com· 5 hours agoOn Tuesday, the Federal Trade Commission (FTC) said it is challenging hundreds of what it calls...
CJEU: Foreign patent invalidity defence in cross-border case - Attorney General Emiliou Delivers...
JD Supra· 18 hours agoThe background of this case is that BSH brought an action before a Swedish court against the Swedish company Electrolux for infringement of the national parts of a European patent< ...